PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 8858385

Autoimmune polyendocrinopathy--candidiasis--ectodermal dystrophy (APECED).

J Perheentupa
View original source ↗Export metadata ↓

Abstract

APECED, an autosomal recessive disease manifests itself as a widely variable combination of three groups of components: 1) autoimmune destruction of tissues, predominantly endocrine glands, 2) chronic superficial candidiasis, and 3) ectodermal dystrophy. Clinical and basic information obtained from Finnish series of 72 patients is reviewed.

Explore related subjects

Addison DiseaseAdolescentAdultAutoimmunityCandidiasisChildChild, PreschoolDiabetes Mellitus, Type 1FemaleHumansHypoparathyroidismHypothyroidismIncidenceInfantMaleMiddle AgedPolyendocrinopathies, AutoimmuneJournal ArticleReview

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

J Perheentupa. 1996. Autoimmune polyendocrinopathy--candidiasis--ectodermal dystrophy (APECED).. https://doi.org/10.1055/s-2007-979814

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed1999

A conformation-dependent epitope in Addison's disease and other endocrinological autoimmune diseases maps to a carboxyl-terminal functional domain of human steroid 21-hydroxylase.

Idiopathic Addison's disease develops as a consequence of autoimmune destruction of steroid-producing cells in the adrenal gland. A major autoantigen is 21-hydroxylase (21OH; P450c21), which is involved in the biosynthesis of cortisol and aldosterone in the adrenal cortex. We selected a number of functionally important 21OH amino acid substitutions, found in patients with congenital adrenal hyperplasia, to study their effects on the binding of 21OH autoantibodies (21OHAb) to 21OH. The ability of 21OHAb to bind in vitro transcribed and translated wild-type 21OH and five different 21OH mutant proteins was quantified by liquid-phase assays. Sera from 21OHAb-positive patients with idiopathic Addison's disease (n = 24), Graves' disease (n = 3), and insulin-dependent diabetes mellitus (n = 1) were used. While the P105L, delE196, and G291S mutations had no effect on autoantibody binding, the P453S mutation had a considerable effect, and the R483P mutation almost completely abolished binding. Synthetic peptides corresponding to linear epitopes defined by amino acids 447-461 and 477-491 were unable to compete with wild-type 21OH for binding to autoantibodies. Direct 21OH DNA sequencing could not reveal any specific genetic variation in alleles found in 21OHAb-positive patients. We conclude that the region involving R483 plays a key role in the formation of a three-dimensional epitope in a functionally important C-terminal domain of the enzyme.

Addison Disease↗